Expertise in
48
conditions

Dr. Brian E. Persing

Oncology
Singing River Health System
2809 Denny Ave, 
Pascagoula, MS 
Accepting New Patients
Offers Telehealth
Expertise in
48
conditions
Singing River Health System
2809 Denny Ave, 
Pascagoula, MS 

Overview

Brian Persing is an Oncologist practicing medicine in Pascagoula, Mississippi.

Dr. Persing is highly rated in 48 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), and Adult Soft Tissue Sarcoma.

He is actively involved in clinical research, co-authoring 1 peer reviewed article and participating in 3 clinical trials. Dr. Persing is currently accepting new patients.

Specialties

Oncology

Licenses

Internal Medicine in MS

Hospital Affiliations

Singing River Health System
Singing River Gulfport

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Magnolia Health
  • HMO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 7 Less Insurance Carriers -

Locations

Singing River Health System
2809 Denny Ave, Pascagoula, MS 39581
Other Locations
Singing River Health System
3535 Bienville Blvd, Ocean Springs, MS 39564

Additional Areas of Focus

Dr. Persing has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Metastatic Uveal Melanoma

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Multicenter, Open-label, Single-arm Phase II Study to Evaluate Anti-tumor Efficacy and Safety of NT-I7 in Combination With Atezolizumab in Subjects With Previously Untreated, PD-L1-expressing, Locally Advanced or Metastatic NSCLC
A Multicenter, Open-label, Single-arm Phase II Study to Evaluate Anti-tumor Efficacy and Safety of NT-I7 in Combination With Atezolizumab in Subjects With Previously Untreated, PD-L1-expressing, Locally Advanced or Metastatic NSCLC
Enrollment Status: Terminated
Publish Date: June 11, 2026
Intervention Type: Drug
Study Drugs: Efineptakin alfa, Atezolizumab
Study Phase: Phase 2
Phase II/III Study of Circulating Tumor DNA as a Predictive Biomarker in Adjuvant Chemotherapy in Patients With Stage IIA Colon Cancer (COBRA)
Phase II/III Study of Circulating Tumor DNA as a Predictive Biomarker in Adjuvant Chemotherapy in Patients With Stage IIA Colon Cancer (COBRA)
Enrollment Status: Active_not_recruiting
Publish Date: May 07, 2025
Intervention Type: Drug, Other
Study Drugs: Capecitabine, 5-Fluorouracil, Leucovorin, Oxaliplatin
Study Phase: Phase 2/Phase 3
A Phase 2 Randomized, Multicenter, Double-Blind Study of the Glutaminase Inhibitor Telaglenastat With Pembrolizumab and Chemotherapy Versus Placebo With Pembrolizumab and Chemotherapy in First-Line, Metastatic KEAP1/NRF2-Mutated, Nonsquamous, Non-Small Cell Lung Cancer (NSCLC)
A Phase 2 Randomized, Multicenter, Double-Blind Study of the Glutaminase Inhibitor Telaglenastat With Pembrolizumab and Chemotherapy Versus Placebo With Pembrolizumab and Chemotherapy in First-Line, Metastatic KEAP1/NRF2-Mutated, Nonsquamous, Non-Small Cell Lung Cancer (NSCLC)
Enrollment Status: Terminated
Publish Date: September 21, 2022
Intervention Type: Drug, Dietary supplement, Biological
Study Drugs: Telaglenastat, Carboplatin Chemotherapy, Pemetrexed Chemotherapy, Pembrolizumab Immunotherapy, Dexamethasone
Study Phase: Phase 2
View 2 Less Clinical Trials

1 Total Publications

Using Federal, State, and Grassroots Advocacy to Effect Change in Cancer Care Delivery and Patient Outcomes in the United States.
Using Federal, State, and Grassroots Advocacy to Effect Change in Cancer Care Delivery and Patient Outcomes in the United States.
Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: May 23, 2024
Similar Doctors
Expertise in
28
conditions
Expertise in
28
conditions
Referral may be required

Singing River Health System

2809 Denny Ave, 
Pascagoula, MS 
 (0.1 miles away)
228-809-5251
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Techksell Washington is an Oncologist practicing medicine in Pascagoula, Mississippi. Dr. Washington is highly rated in 28 conditions, according to our data. Her clinical expertise encompasses Angiosarcoma, Paget Disease of the Breast, Inflammatory Breast Cancer, and Unicentric Castleman Disease (UCD). Dr. Washington is currently accepting new patients.

Expertise in
10
conditions
Expertise in
10
conditions
Referral may be required

Singing River Health System

2101 Highway 90, 
Gautier, MS 
 (6.6 miles away)
228-809-5251
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Michael Finan is an Oncologist practicing medicine in Gautier, Mississippi. Dr. Finan is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Ovarian Cancer, Virilizing Ovarian Tumor, Testicular Yolk Sac Tumor, Bladder Reconstruction, and Splenectomy. Dr. Finan is currently accepting new patients.

Expertise in
30
conditions
Expertise in
30
conditions
Referral may be required

Memorial Infusion Clinic-Cedar Lake

920 Tommy Munro Dr Ste 100, 
Biloxi, MS 
 (26.9 miles away)
228-575-1234
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Purushottam Pande is an Oncologist practicing medicine in Biloxi, Mississippi. Dr. Pande is highly rated in 30 conditions, according to our data. His clinical expertise encompasses B-Cell Lymphoma, Hemangioma Thrombocytopenia Syndrome, Non-Hodgkin Lymphoma, Bone Marrow Aspiration, and Endoscopy. Dr. Pande is currently accepting new patients.

Frequently Asked Questions about Dr. Brian E. Persing

How do I make an appointment with Dr. Brian E. Persing?

You can book an appointment with Dr. Brian E. Persing by calling their office at 228-809-5251. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Brian E. Persing a top-rated expert for Lung Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Brian E. Persing is classified as an Distinguished expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Brian E. Persing specialize in?

While Dr. Brian E. Persing is a Oncology, they have specific expertise in Lung Cancer, Pleuropulmonary Blastoma, and Small Cell Lung Cancer (SCLC). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Brian E. Persing participate in research or clinical trials?

Yes. Dr. Brian E. Persing has published 1 articles and abstracts on conditions like Lung Cancer. You can view a list of Dr. Brian E. Persing's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Brian E. Persing accept my insurance?

Dr. Brian E. Persing accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 228-809-5251 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Persing's expertise for a condition
ConditionClose
    View All 43 Advanced Conditions
    View All 100 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile